Molecular Basis of Autosomal Dominant Hypercholesterolemia
Authors:
- 22 March 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 123 (11) , 1167-1173
Abstract
Background—: Autosomal dominant hypercholesterolemia (ADH) is characterized by elevated low-density lipoprotein cholesterol levels and premature cardiovascular disease. Mutations in the genes encoding for low-density lipoprotein receptor ( LDLR ), apolipoprotein B ( APOB ), and proprotein convertase subtilisin/kexin 9 ( PCSK9 ) underlie ADH. Nevertheless, a proportion of individuals who exhibit the ADH phenotype do not carry mutations in any of these 3 genes. Estimates of the percentage of such cases among the ADH phenotype vary widely. We therefore investigated a large pediatric population with an unequivocal ADH phenotype to assess the molecular basis of hereditary hypercholesterolemia and to define the percentage of individuals with unexplained dyslipidemia. Methods and Results—: We enrolled individuals with low-density lipoprotein cholesterol levels above the 95th percentile for age and gender and an autosomal dominant inheritance pattern of hypercholesterolemia from a large referred pediatric cohort of 1430 children. We excluded children with thyroid dysfunction, nephrotic syndrome, autoimmune disease, liver disease, primary biliary cirrhosis, and obesity (body mass index >75th percentile for age and gender), as well as children referred via a cascade screening program and those from families with a known molecular diagnosis. Of the 269 children who remained after the exclusion criteria were applied, 255 (95%) carried a functional mutation ( LDLR , 95%; APOB , 5%). Conclusion—: In the vast majority of children with an ADH phenotype, a causative mutation can be identified, strongly suggesting that most of the large-effect genes underlying ADH are known to date.Keywords
This publication has 26 references indexed in Scilit:
- Biological, clinical and population relevance of 95 loci for blood lipidsNature, 2010
- Molecular characterization of Polish patients with familial hypercholesterolemia: novel and recurrentLDLR mutationsJournal of Applied Genetics, 2010
- Using BMI to Determine Cardiovascular Risk in Childhood: How Do the BMI Cutoffs Fare?Pediatrics, 2009
- Growth Curves for Cardio-Metabolic Risk Factors in Children and AdolescentsThe Journal of Pediatrics, 2009
- Familial hypercholesterolaemia: summary of NICE guidanceBMJ, 2008
- Update of the molecular basis of familial hypercholesterolemia in The NetherlandsHuman Mutation, 2005
- Mutations in PCSK9 cause autosomal dominant hypercholesterolemiaNature Genetics, 2003
- The molecular basis of familial hypercholesterolemia in The NetherlandsHuman Genetics, 2001
- Familial ligand-defective apolipoprotein B. Identification of a new mutation that decreases LDL receptor binding affinity.Journal of Clinical Investigation, 1995
- Familial combined hyperlipidemia in children: Clinical expression, metabolic defects, and managementThe Journal of Pediatrics, 1993